The IPO subscription period for individual subscribers will begin on Tuesday, July 18, 1445H (corresponding to 30-01-2024G) and end on Thursday, July 20, 1445H (corresponding to 01-02-2024G). A maximum of 600,000 shares, representing 10% of the company's shares, will be allocated to individual subscribers. Aldukheil Financial Group "Aldukheil," in its capacity as Financial Advisor and Bookrunner for the Initial Public Offering of The Middle East Pharmaceutical Industries company "Avalon Pharma" ("the Company") on the Main Market, announces that the book building process has been successfully concluded for the total of (6,000,000) ordinary shares representing (30%) of the Company's shares ("the Offering"; the Offering Price was determined at SAR 82 per share, with a coverage of 138.76 times of the total shares offered. Please refer to the prospectus found on the following websites for more information: www.avalonpharmaceutical.com, www.aldukheil.com.sa, www.capitalmarketauthority.com.sa, and www.cma.org.sa, the website of the company. You can also read more information by clicking on the attached file.
